MARKET

FWP

FWP

Forward Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8400
+0.0058
+0.70%
Closed 16:00 11/14 EST
OPEN
0.8400
PREV CLOSE
0.8342
HIGH
0.8400
LOW
0.8400
VOLUME
1.60K
TURNOVER
--
52 WEEK HIGH
1.640
52 WEEK LOW
0.7101
MARKET CAP
19.82M
P/E (TTM)
-6.3158
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FWP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FWP News

  • The Top ADRs To Buy Now
  • Seeking Alpha - Article.10/23 16:31
  • Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock Exchange
  • GlobeNewswire.06/26 21:30
  • Introducing Forward Pharma (NASDAQ:FWP), The Stock That Collapsed 95%
  • Simply Wall St..05/27 13:49
  • Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2018
  • GlobeNewswire.04/04 21:30

More

Industry

Biotechnology & Medical Research
-0.05%
Pharmaceuticals & Medical Research
-0.28%

Hot Stocks

Name
Price
%Change

About FWP

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development for the treatment of relapsing remitting MS (RRMS) and other immune disorders, such as psoriasis. The Company's DMF formulation, FP187, employs over two methods, which improves the release of DMF by reducing the peaks of monomethyl fumarate (MMF) in the bloodstream while maintaining overall DMF exposure levels, which, in turn, controls DMF's side effects. The Company has conducted a pre-clinical program and has completed several Phase I and Phase II clinical trials for the product FP187.
More

Webull offers Forward Pharma A/S (FWP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.